Trials / Completed
CompletedNCT00092157
Effectiveness of Two Approved Drugs in Lowering High Cholesterol (0733-224)
A Multicenter, Randomized, Double-Blind, Parallel Group Study to Evaluate the Tolerability and Efficacy of the Co-Administration of Simvastatin 20 mg/Day and Fenofibrate 160 mg/Day Compared to Simvastatin 20 mg/Day Alone for 12 Weeks of Treatment in Patients With Combined Hyperlipidemia-Simvastatin and Fenofibrate Efficacy Trial (SAFARI)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 571 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and effectiveness of two approved drugs in lowering high cholesterol when taken together, compared to taking only one of the drugs.
Detailed description
The duration of treatment is 12 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0733, simvastatin | |
| DRUG | Comparator: simvastatin |
Timeline
- Start date
- 2002-05-01
- Primary completion
- 2003-03-03
- Completion
- 2003-03-04
- First posted
- 2004-09-24
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00092157. Inclusion in this directory is not an endorsement.